Safety profile
25 studies reporting safety data2 serious adverse events
Across 25 clinical studies, no specific adverse events were found to be increased with Lactobacillus reuteri DSM 17938 compared to control. In 18 studies, no significant differences were observed for events such as crying time, spitting-up, colic, and gastrointestinal symptoms, with some outcomes favoring the probiotic. The supplement was described as well tolerated in 26 mentions, and serious adverse events were not attributed to the probiotic. Overall, the evidence indicates a favorable safety profile in the studied populations, primarily infants and children.
Caveats: Most studies were short-term (typically ≤8 weeks) and focused on infant populations; long-term safety and effects in adults or immunocompromised individuals are not well characterized. Many trials were powered for efficacy rather than safety, so rare adverse events may not have been detected.